Clover Health Investments Corp ( (CLOV) ) has released its Q2 earnings. Here is a breakdown of the information Clover Health Investments Corp presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Clover Health Investments Corp. is a technology-driven healthcare company specializing in Medicare Advantage plans, leveraging its proprietary Clover Assistant platform to enhance patient care and outcomes. In its second quarter of 2025 earnings report, Clover Health reported significant growth in Medicare Advantage membership and total revenues, alongside a narrowed net loss and positive adjusted EBITDA and net income figures. Key financial highlights include a 32% year-over-year increase in Medicare Advantage membership to 106,323 and a 34% rise in total revenues to $478 million. Despite a GAAP net loss of $11 million, the company achieved an adjusted EBITDA of $17 million and an adjusted net income of $17 million. The company also updated its full-year 2025 guidance, maintaining its insurance revenue forecast and adjusted EBITDA and net income targets while improving its adjusted SG&A expectations. Looking ahead, Clover Health’s management remains optimistic about sustaining growth and profitability, emphasizing its technology-first approach and commitment to improving health outcomes for its members.